Gelnique (oxybutynin chloride) 10% gel for overactive bladder
Lajiness, M.J.
Urologic Nursing 30(4): 253-254
2010
ISSN/ISBN: 1053-816X PMID: 20949812 Document Number: 640896
This article provides an overview of oxybutynin transdermal gel (Gelnique), its uses, and product information.
Document emailed within 1 workday
Related Documents
Goto, M.; Kato, K.; Kondo, A.; Otani, T.; Takita, T.; Kobayashi, M. 1988: Clinical effects of oxybutynin hydrochloride in the treatment of unstable bladder and overactive neurogenic bladder: a long-term clinical trial Hinyokika Kiyo. Acta Urologica Japonica 34(3): 541-550Merino Salas, S. 2018: Maintenance of the efficacy of the oxybutynin patch for the treatment of overactive bladder syndrome despite the change in the area of application: study of four cases Archivos Espanoles de Urologia 71(5): 502-505
Fröhlich, G.; Burmeister, S.; Wiedemann, A.; Bulitta, M. 1998: Intravesical instillation of trospium chloride, oxybutynin and verapamil for relaxation of the bladder detrusor muscle. a placebo controlled, randomized clinical test Arzneimittel-Forschung 48(5): 486-491
Riva, D.; Casolati, E. 1984: Oxybutynin chloride in the treatment of female idiopathic bladder instability. Results from double blind treatment Clinical and Experimental Obstetrics and Gynecology 11(1-2): 37-42
Jonville, A.P.; Dutertre, J.P.; Barbellion, M.; Autret, E. 1993: Adverse effects of oxybutynin chloride (Ditropan) in pediatrics Archives Francaises de Pediatrie 50(1): 27-29
Soontrapa, S.; Ruksakul, W.; Nonthasood, B.; Tappayuthpijarn, P. 2003: The efficacy of Thai capsaicin in management of overactive bladder and hypersensitive bladder Journal of the Medical Association of Thailand 86(9): 861-867
Batista Miranda, J.E.; Arañó Bertran, P.; Caffaratti, J.; Regalado Pareja, R.; Garat Barredo, J.M.; Errando Smet, C.; Vicente Rodríguez, J. 1997: Efficacy of oxybutynin chloride in children with vesico-ureteral reflux and detrusor instability Anales Espanoles de Pediatria 47(3): 251-257
Serrano Brambila, E.A.; Quiroga Avila, R.G.; Lorenzo Monterrubio, J.L.; Moreno Aranda, J. 2000: Assessment of effectiveness of and tolerance to oxybutynin in the treatment of unstable bladder in women Ginecologia y Obstetricia de Mexico 68: 174-181
Kul'chavenia, E.V.; Breusov, A.A.; Kholtobin, D.P. 2011: Overactive bladder as a cause of sexual dysfunction Urologiia 5: 87-89
Nowara, A.; Witek, A.; Wilk, K. 2007: Diagnostic and treatment of overactive bladder Ginekologia Polska 78(7): 549-553
Golomb, J. 2000: Treatment of the overactive bladder with detrusitol Harefuah 139(11-12): 467-470
Kubota, Y.; Sasaki, S.; Kojima, Y.; Hayase, M.; Kohri, K. 2007: Overactive bladder in female and new strategy Hinyokika Kiyo. Acta Urologica Japonica 53(6): 435-439
Epstein, B.J.; Gums, J.G.; Molina, E. 2006: Newer agents for the management of overactive bladder American Family Physician 74(12): 2061-2068
Nowara, A.; Witek, A.; Wilk, K. 2007: Overactive bladder--definition, epidemiology, pathogenesis Ginekologia Polska 78(6): 484-487
Khaled, S.M.; Elhilali, M. 2003: Role of 5-HT receptors in treatment of overactive bladder Drugs of Today 39(8): 599-607
Kupriyanov, Y.A.; Kasyan, G.R.; Pushkar, D.Y. 2018: A role of fesoterodine in treatment of overactive bladder Urologiia 6: 155-162
Prasopsanti, K.; Santi-Ngamkun, A.; Pornprasit, K. 2007: Estimated cost of overactive bladder in Thailand Journal of the Medical Association of Thailand 90(11): 2316-2320
Patterson, A. 2011: Behaviour change to treat overactive bladder syndrome Nursing Times 107(46): 16; 18-19
Al'-Shukri, S.K.; Kuz'min, I.V. 2008: Assessment of symptoms severity in patients with overactive bladder Urologiia 6: 37-40
Ogushi, T.; Takahashi, S. 2007: Effect of Chinese herbal medicine on overactive bladder Hinyokika Kiyo. Acta Urologica Japonica 53(12): 857-862